{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:08:48Z","timestamp":1793916528170,"version":"4.8.0"},"reference-count":40,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2024,4,14]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                  <jats:title>Background and objectives<\/jats:title>\n                  <jats:p>Although left atrial appendage closure (LAAC) is performed in patients with non-valvular atrial fibrillation (NVAF) at increased risk of intracranial haemorrhage (ICH), outcome data are scarce. We assessed the detailed neurological indications for LAAC and outcomes after LAAC in high ICH risk patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Study population included consecutive patients with NVAF who underwent LAAC in a single hospital network between January 2015 and October 2021 because of prior ICH or the presence of high ICH risk imaging markers on brain MRI (cerebral microbleeds (CMBs)). Primary safety and efficacy outcome measures were the occurrence of ICH and thromboembolic events, respectively, after LAAC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 146 patients with NVAF who underwent LAAC for high ICH risk, 122 had a history of ICH, while 24 presented with high ICH risk imaging markers only. Mean age was 75.7\u00b17.61, 42 (28.8%) were women. Mean CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score was 5.23\u00b11.52. Of 122 patients with ICH history, 58 (47.5%) had intraparenchymal haemorrhage (IPH), 40 (32.8%) had traumatic ICH (T-ICH) and 18 (14.7%) had non-traumatic subdural haemorrhage. Of 85 patients with brain MRIs including necessary sequences, 43 (50.6%) were related to cerebral amyloid angiopathy and 37 (43.5%) to hypertensive microangiopathy. While 70% of patients were discharged on oral anticoagulants (OAC), 92% were not taking OAC at 1 year. Over 2.12 years mean follow-up, one patient had recurrent non-traumatic IPH (incidence rate (IR) 0.32 per 100 patient-years), five had T-ICH (IR 1.61 per 100 patient-years) and six had an ischaemic stroke (IR 1.94 per 100 patient-years).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Among patients with NVAF at high ICH risk, LAAC demonstrated a low risk of recurrent ICH or ischaemic stroke compared with previously published data. LAAC in high ICH risk populations should be considered in clinical practice per FDA approval and recent guidelines.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/svn-2024-003142","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T01:57:23Z","timestamp":1717120643000},"page":"86-94","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Left atrial appendage closure for patients with atrial fibrillation at high intracranial haemorrhagic risk"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7483-8193","authenticated-orcid":false,"given":"Avia","family":"Abramovitz Fouks","sequence":"first","affiliation":[{"name":"Neurology, Massachussets General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Yaghi","sequence":"additional","affiliation":[{"name":"Neurology, Brown University, Warren Alpert Medical School, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Gokcal","sequence":"additional","affiliation":[{"name":"Neurology, Massachussets General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2313-977X","authenticated-orcid":false,"given":"Alvin S","family":"Das","sequence":"additional","affiliation":[{"name":"Neurology, Massachussets General Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Rotschild","sequence":"additional","affiliation":[{"name":"Neurology, Massachussets General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B","family":"Silverman","sequence":"additional","affiliation":[{"name":"Neurology, Massachussets General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh B","family":"Singhal","sequence":"additional","affiliation":[{"name":"Neurology, Massachussets General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Romero","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kapur","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Neurology, Massachussets General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut Edip","family":"Gurol","sequence":"additional","affiliation":[{"name":"Neurology, Massachussets General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"2025082410450067000_10.1.86.1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004797"},{"key":"2025082410450067000_10.1.86.2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004665"},{"key":"2025082410450067000_10.1.86.3","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1212\/WNL.0000000000004704","article-title":"Brain Microbleeds, anticoagulation, and hemorrhage risk: meta-analysis in stroke patients with AF","volume":"89","author":"Charidimou","year":"2017","journal-title":"Neurology"},{"key":"2025082410450067000_10.1.86.4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S1474-4422(21)00264-7","article-title":"Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial","volume":"20","author":"Al-Shahi Salman","year":"2021","journal-title":"The Lancet Neurology"},{"key":"2025082410450067000_10.1.86.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00298-2"},{"key":"2025082410450067000_10.1.86.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30145-5"},{"key":"2025082410450067000_10.1.86.7","doi-asserted-by":"crossref","first-page":"e2432","DOI":"10.1212\/WNL.0000000000007532","article-title":"MRI predicts intracranial hemorrhage in patients who receive long-term oral anticoagulation","volume":"92","author":"Mart\u00ed-F\u00e0bregas","year":"2019","journal-title":"Neurology"},{"key":"2025082410450067000_10.1.86.8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/B978-0-12-819814-8.00021-4","article-title":"The role of biomarkers and neuroimaging in ischemic\/hemorrhagic risk assessment for cardiovascular\/cerebrovascular disease prevention","volume":"177","author":"Gokcal","year":"2021","journal-title":"Handb Clin Neurol"},{"key":"2025082410450067000_10.1.86.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11333-2"},{"key":"2025082410450067000_10.1.86.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15192"},{"key":"2025082410450067000_10.1.86.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.04.029"},{"key":"2025082410450067000_10.1.86.12","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.017081"},{"key":"2025082410450067000_10.1.86.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057063"},{"key":"2025082410450067000_10.1.86.14","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2018.03608"},{"key":"2025082410450067000_10.1.86.15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70124-8"},{"key":"2025082410450067000_10.1.86.16","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70013-4"},{"key":"2025082410450067000_10.1.86.17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv162"},{"key":"2025082410450067000_10.1.86.18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.9.1683"},{"key":"2025082410450067000_10.1.86.19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.86.16_supplement.P3.192"},{"key":"2025082410450067000_10.1.86.20","doi-asserted-by":"crossref","first-page":"e1646","DOI":"10.1212\/WNL.0000000000011631","article-title":"Lacunes, Microinfarcts, and vascular dysfunction in cerebral Amyloid Angiopathy","volume":"96","author":"Gokcal","year":"2021","journal-title":"Neurology"},{"key":"2025082410450067000_10.1.86.21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003746"},{"key":"2025082410450067000_10.1.86.22","doi-asserted-by":"crossref","first-page":"e2192","DOI":"10.1212\/WNL.0000000000010788","article-title":"Association of enlarged Perivascular spaces and anticoagulant-related intracranial hemorrhage","volume":"95","author":"Best","year":"2020","journal-title":"Neurology"},{"key":"2025082410450067000_10.1.86.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00208-3"},{"key":"2025082410450067000_10.1.86.24","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207476"},{"key":"2025082410450067000_10.1.86.25","doi-asserted-by":"crossref","first-page":"e774","DOI":"10.1212\/WNL.0000000000006953","article-title":"Microangiopathy underlying mixed-location intracerebral hemorrhages\/Microbleeds: A Pib-PET study","volume":"92","author":"Tsai","year":"2019","journal-title":"Neurology"},{"key":"2025082410450067000_10.1.86.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70340-0"},{"key":"2025082410450067000_10.1.86.27","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(23)02025-1","article-title":"Anticoagulation in patients with cerebral Amyloid Angiopathy","volume":"402","author":"Shoamanesh","year":"2023","journal-title":"Lancet"},{"key":"2025082410450067000_10.1.86.28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cjco.2023.03.004","article-title":"Stroke prevention with left atrial appendage closure in patients with atrial fibrillation and prior intracranial hemorrhage","volume":"5","author":"Gilhofer","year":"2023","journal-title":"CJC Open"},{"key":"2025082410450067000_10.1.86.29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology: final 2-year outcome data of the EWOLUTION trial focusing on history of stroke and hemorrhage","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025082410450067000_10.1.86.30","doi-asserted-by":"crossref","unstructured":"Ajmal M , Sipra Q , Pecci C , et al . Feasibility of left atrial appendage closure in atrial fibrillation patients with a history of intracranial bleeding: A systematic review of observational studies. J Interv Cardiol 2020;1575839.","DOI":"10.1155\/2020\/1575839"},{"key":"2025082410450067000_10.1.86.31","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000491"},{"key":"2025082410450067000_10.1.86.32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr488"},{"key":"2025082410450067000_10.1.86.33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/STROKEAHA.123.040447","article-title":"Stroke prevention in atrial fibrillation: our current failures and required research","volume":"55","author":"Gurol","year":"2024","journal-title":"Stroke"},{"key":"2025082410450067000_10.1.86.34","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jacep.2023.04.013","article-title":"Enhanced Thromboresistance and Endothelialization of a novel Fluoropolymer-coated left atrial appendage closure device","volume":"9","author":"Saliba","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2025082410450067000_10.1.86.35","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193"},{"key":"2025082410450067000_10.1.86.36","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/WNL.0000000000003866","article-title":"Cortical superficial Siderosis and first-ever cerebral hemorrhage in cerebral Amyloid Angiopathy","volume":"88","author":"Charidimou","year":"2017","journal-title":"Neurology"},{"key":"2025082410450067000_10.1.86.37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016261"},{"key":"2025082410450067000_10.1.86.38","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.005151"},{"key":"2025082410450067000_10.1.86.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.02.047"},{"key":"2025082410450067000_10.1.86.40","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.hrthm.2018.11.022","article-title":"Left atrial appendage closure device implantation in patients with prior intracranial hemorrhage","volume":"16","author":"Hutt","year":"2019","journal-title":"Heart Rhythm"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2024-003142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T17:45:11Z","timestamp":1756057511000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2024-003142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,25]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/svn-2024-003142"],"URL":"https:\/\/doi.org\/10.1136\/svn-2024-003142","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}